Fourth national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from patients with complicated urinary tract infections

被引：2

作者：

Kobayashi, Kanao ^{[1
,2
,3
,6
]}

Takahashi, Satoshi ^{[1
,2
,3
,7
]}

Yasuda, Mitsuru ^{[1
,2
,3
,7
]}

Miyazaki, Jun ^{[1
,2
,3
,8
]}

Wada, Koichiro ^{[1
,2
,3
,9
]}

Matsumoto, Masahiro ^{[1
,2
,3
,10
]}

Hayami, Hiroshi ^{[1
,2
,3
,11
]}

Yamamoto, Shingo ^{[4
,5
,12
]}

Kiyota, Hiroshi ^{[4
,5
,13
]}

Sato, Junko ^{[4
,5
]}

Matsumoto, Tetsuya ^{[4
,5
]}

Hasegawa, Naoki ^{[4
,5
]}

Kobayashi, Intetsu ^{[14
]}

Masumori, Naoya ^{[15
]}

Kimura, Takahiro ^{[16
]}

Yamada, Hiroki ^{[17
]}

Nakagawa, Tohru ^{[18
]}

Kaneko, Tomoyuki ^{[18
]}

Matsumoto, Kazumasa ^{[19
]}

Fujimura, Tetsuya ^{[20
]}

Kamei, Jun ^{[20
]}

Ishikawa, Kiyohito ^{[21
]}

Fujimoto, Kiyohide ^{[22
]}

Nakai, Yasushi ^{[22
]}

Shigemura, Katsumi ^{[23
]}

Sadahira, Takuya ^{[24
]}

Hinata, Nobuyuki ^{[25
]}

Kitano, Hiroyuki ^{[26
]}

Yamashita, Masuo ^{[26
]}

Yasufuku, Tomihiko ^{[26
]}

Komeda, Hisao ^{[27
]}

Hiyama, Yoshiki ^{[28
]}

Takahashi, Yoshito ^{[29
]}

Kanamaru, Sojun ^{[30
]}

Murakami, Masaya ^{[31
]}

Arakawa, Soichi ^{[32
]}

Yamada, Daisuke ^{[33
]}

Mita, Koji ^{[34
]}

Hamasuna, Ryoichi ^{[35
]}

Tanaka, Kazushi ^{[36
]}

Matsukawa, Masanori ^{[37
]}

Takaoka, Eiichiro ^{[38
]}

Shigeta, Masanobu ^{[39
]}

Takenaka, Tadasu ^{[40
]}

Nishino, Masashi ^{[41
]}

Ishitoya, Satoshi ^{[42
]}

Hayakawa, Shohei ^{[43
]}

Okumura, Kazuhiro ^{[44
]}

Ueda, Masakatsu ^{[44
]}

机构：

[1] Japanese Assoc Infect Dis JAID, Urogenital Sub Comm, Tokyo, Japan

[2] Japanese Assoc Infect Dis JAID, Surveillance Comm Japanese Soc Chemotherapy JSC, Tokyo, Japan

[3] Japanese Soc Clin Microbiol JSCM, Tokyo, Japan

[4] JAID, Surveillance Comm JSC, Tokyo, Japan

[5] JSCM, Tokyo, Japan

[6] Chugoku Rosai Hosp, Dept Urol, Japan Org Occupat Hlth & Safety, Kure, Hiroshima, Japan

[7] Sapporo Med Univ, Dept Infect Control & Lab Med, Sch Med, Hokkaido, Japan

[8] Int Univ Hlth & Welf, Ichikawa Hosp, Dept Urol, Chiba, Japan

[9] Shimane Univ, Dept Urol, Fac Med, Shimane, Japan

[10] Univ Occupat & Environm Hlth, Dept Urol, Fukuoka, Japan

[11] Hanafusa Urol Clin, Miyazaki, Japan

[12] Hyogo Coll Med, Dept Urol, Hyogo, Japan

[13] Iguchi Nephrourol & Internal Med Clin Shinkoiwa, Tokyo, Japan

[14] Toho Univ, Dept Infect Control & Prevent, Fac Nursing, Tokyo, Japan

[15] Sapporo Med Univ, Dept Urol, Sch Med, Hokkaido, Japan

[16] Jikei Univ, Dept Urol, Sch Med, Tokyo, Japan

[17] Jikei Univ, Dept Urol, Katsushika Med Ctr, Tokyo, Japan

[18] Teikyo Univ, Dept Urol, Sch Med, Tokyo, Japan

[19] Kitasato Univ, Dept Urol, Sch Med, Sagamihara, Kanagawa, Japan

[20] Jichi Med Univ, Dept Urol, Tochigi, Japan

[21] Fujita Hlth Univ, Sch Med, Dept Urol, Toyoake, Aichi, Japan

[22] Nara Med Univ, Dept Urol, Nara, Japan

[23] Kobe Univ, Div Urol, Grad Sch Med, Hyogo, Japan

[24] Okayama Univ, Dept Urol, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan

[25] Hlth Sci Hiroshima Univ, Grad Sch Biomed, Dept Urol, Hiroshima, Japan

[26] Shinko Hosp, Dept Urol, Hyogo, Japan

[27] Gifu Municipal Hosp, Dept Urol, Gifu, Japan

[28] Hakodate Goryokaku Hosp, Dept Urol, Hokkaido, Japan

[29] Gifu Prefectural Gen Med Ctr, Dept Urol, Gifu, Japan

[30] Kobe City Nishi Kobe Med Ctr, Dept Urol, Hyogo, Japan

[31] Fuji City Gen Hosp, Dept Urol, Shizuoka, Japan

[32] Sanda City Hosp, Dept Urol, Hyogo, Japan

[33] Mitoyo Gen Hosp, Dept Urol, Kanonji, Kagawa, Japan

[34] Hiroshima City North Med Ctr Asa Citizens Hosp, Hiroshima City Asa Citizens Hosp, Dept Urol, Hiroshima, Japan

[35] Shin Kokura Hosp, Dept Urol, Fukuoka, Japan

[36] Kita Harima Med Ctr, Dept Urol, Hyogo, Japan

[37] Takikawa Municipal Hosp, Dept Urol, Hokkaido, Japan

[38] Int Univ Hlth & Welf Hosp, Dept Urol, Tochigi, Japan

[39] Natl Hosp Org Kure Med Ctr, Chugoku Canc Ctr, Dept Urol, Hiroshima, Japan

[40] Japanese Red Cross Okayama Hosp, Dept Urol, Okayama, Japan

[41] Japanese Red Cross Hamamatsu Hosp, Dept Urol, Shizuoka, Japan

[42] Japanese Red Cross Otsu Hosp, Dept Urol, Shiga, Japan

[43] Japanese Red Cross Shizuoka Hosp, Dept Urol, Shizuoka, Japan

[44] Tenri Hosp, Dept Urol, Nara, Japan

来源：

JOURNAL OF INFECTION AND CHEMOTHERAPY | 2024年 / 30卷 / 07期

关键词：

Antimicrobial susceptibility pattern; Complicated urinary tract infection; Minimum inhibitory concentration; Surveillance; ESCHERICHIA-COLI; FLOMOXEF;

D O I：

10.1016/j.jiac.2024.03.024

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Introduction: Antimicrobial susceptibility patterns of bacterial pathogens isolated from patients with complicated urinary tract infections were analyzed using the national surveillance data, comprising 793 bacterial strains from eight clinically relevant species. Materials and methods: Data were collected for the fourth national surveillance project from July 2020 to December 2021 by the Japanese Society of Chemotherapy, the Japanese Association for Infectious Disease, and the Japanese Society of Clinical Microbiology. Surveillance was supervised with the cooperation of 43 medical institutions throughout Japan. Results: Fluoroquinolone required a minimum inhibitory concentration (MIC) of 2 -64 mg/L to inhibit the 330 tested Escherichia coli strains. The proportion of levofloxacin-resistant E. coli strains increased from 28.6% in 2008 to 29.6% in 2011, 38.5% in 2015, and 44.5% in 2021. The proportion of levofloxacin-resistant strains of Pseudomonas aeruginosa also increased from previous survey results, showing a continuing downward trend. Conversely, the proportion of levofloxacin-resistant strains of Enterococcus faecalis decreased relative to previous reports. Neither multidrug-resistant P. aeruginosa nor carbapenem-resistant Enterobacteriaceae were detected. For methicillin-resistant Staphylococcus aureus (MRSA), the proportion of vancomycin-susceptible strains (MIC of 2 mu g/mL) decreased from 14.7% to 7.7%. Discussion: Bacterial strains that produced extended -spectrum beta-lactamase included E. coli (82/330 strains, 24.8%), Klebsiella pneumoniae (11/68 strains, 16.2%), and Proteus mirabilis (4/26 strains, 15.4%). As compared to previous surveillance reports, these strains showed an increase in proportion over the years.

引用

页码：579 / 589

页数：11

共 17 条

[1] Klebsiella pneumoniae carbapenemase (KPC) in urinary infection isolates
Bedenic, Branka
Sardelic, Sanda
Bogdanic, Maja
Zarfel, Gernot
Beader, Natasa
Suto, Sandra
Krilanovic, Marija
Vranes, Jasmina
[J]. ARCHIVES OF MICROBIOLOGY, 2021, 203 (04) : 1825 - 1831
[2] Clinical and Laboratory Standards Institute, 2021, document M100-Ed31, V31st
[3] Clinical and Laboratory Standards Institute, 2018, Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically
[4] In Vitro Activity and Clinical Efficacy of Faropenem against Third-Generation Cephalosporin-Resistant Escherichia coli and Klebsiella pneumoniae
Ishikawa, Kazuhiro
Uehara, Yuki
Mori, Nobuyoshi
Mikami, Yumiko
Tokioka, Sayuri
Kobayashi, Daiki
Goke, Hisa
Inukai, Tatsuya
Sakurai, Aki
Doi, Yohei
Kawakami, Sayoko
Kayama, Shizuo
Sugai, Motoyuki
Nakamura, Shigeki
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)
[5] Japanese nationwide surveillance in 2011 of antibacterial susceptibility patterns of clinical isolates from complicated urinary tract infection cases
Ishikawa, Kiyohito
Hamasuna, Ryoichi
Uehara, Shinya
Yasuda, Mitsuru
Yamamoto, Shingo
Hayami, Hiroshi
Takahashi, Satoshi
Matsumoto, Tetsuro
Minamitani, Shinichi
Kadota, Jun-ichi
Iwata, Satoshi
Kaku, Mitsuo
Watanabe, Akira
Sunakawa, Keisuke
Sato, Junko
Hanaki, Hideaki
Tsukamoto, Taiji
Kiyota, Hiroshi
Egawa, Shin
Deguchi, Takashi
Matsumoto, Minori
Tanaka, Kazushi
Arakawa, Soichi
Fujisawa, Masato
Kumon, Hiromi
Kobayashi, Kanao
Matsubara, Akio
Wakeda, Hironobu
Amemoto, Yoshinosuke
Onodera, Shoichi
Goto, Hirokazu
Komeda, Hisao
Yamashita, Masuo
Takenaka, Tadasu
Fujimoto, Yoshinori
Tsugawa, Masaya
Takahashi, Yoshito
Maeda, Hiroshi
Onishi, Hiroyuki
Ishitoya, Satoshi
Nishimura, Kazuo
Mitsumori, Kenji
Ito, Toru
Togo, Yoshikazu
Nakamura, Ichiro
Ito, Noriyuki
Kanamaru, Sojun
Hirose, Takaoki
Muranaka, Takashi
Yamada, Daisuke
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2015, 21 (09) : 623 - 633
[6] The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy
Ishikawa, Kiyohito
Matsumoto, Tetsuro
Yasuda, Mitsuru
Uehara, Shinya
Muratani, Tetsuro
Yagisawa, Morimasa
Sato, Junko
Niki, Yoshihito
Totsuka, Kyoichi
Sunakawa, Keisuke
Hanaki, Hideaki
Hattori, Rikizo
Terada, Michinori
Kozuki, Tsuneo
Maruo, Akinori
Morita, Kohei
Ogasawara, Kazuhiko
Takahashi, Yoshisaburo
Matsuda, Kenji
Hirose, Takaoki
Miyao, Noriomi
Hayashi, Tasuku
Takeyama, Koh
Kiyota, Hiroshi
Tomita, Masayuki
Yusu, Hisashi
Koide, Haruhisa
Kimura, Shoji
Yanaoka, Masanori
Sato, Hajime
Ito, Toru
Deguchi, Takashi
Fujimoto, Yoshinori
Komeda, Hisao
Asano, Yuko
Takahashi, Yoshito
Ishihara, Satoshi
Arakawa, Soichi
Nakano, Yuzo
Tanaka, Kazushi
Fujisawa, Masato
Matsui, Takashi
Fujii, Akira
Yamamoto, Shingo
Nojima, Michio
Higuchi, Yoshihide
Ueda, Yasuo
Kanamaru, Sojun
Monden, Koichi
Tsushima, Tomoyasu
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2011, 17 (01) : 126 - 138
[7] Japanese revision committee for the, 2016, J Infect Chemother, V10, P651
[8] Carbapenem-Sparing Strategies for ESBL Producers: When and How
Karaiskos, Ilias
Giamarellou, Helen
[J]. ANTIBIOTICS-BASEL, 2020, 9 (02):
[9] Kobayashi K, 2023, Nishinihon J Urol, V85, P159
[10] The third national Japanese antimicrobial susceptibility pattern surveillance program: Bacterial isolates from complicated urinary tract infection patients
Kobayashi, Kanao
Yamamoto, Shingo
Takahashi, Satoshi
Ishikawa, Kiyohito
Yasuda, Mitsuru
Wada, Koichiro
Hamasuna, Ryoichi
Hayami, Hiroshi
Minamitani, Shinichi
Matsumoto, Tetsuya
Kiyota, Hiroshi
Tateda, Kazuhiro
Sato, Junko
Hanaki, Hideaki
Masumori, Naoya
Hiyama, Yoshiki
Yamada, Hiroki
Egawa, Shin
Kimura, Takahiro
Nishiyama, Hiroyuki
Miyazaki, Jun
Matsumoto, Kazumasa
Homma, Yukio
Kamei, Jun
Fujimoto, Kiyohide
Torimoto, Kazumasa
Tanaka, Kazushi
Togo, Yoshikazu
Uehara, Shinya
Matsubara, Akio
Shoji, Koichi
Goto, Hirokazu
Komeda, Hisao
Ito, Toru
Mori, Katsuhisa
Mita, Koji
Kato, Masao
Fujimoto, Yoshinori
Masue, Takako
Inatomi, Hisato
Takahashi, Yoshito
Ishihara, Satoshi
Nishimura, Kazuo
Mitsumori, Kenji
Ito, Noriyuki
Kanamaru, Sojun
Yamada, Daisuke
Hiroshi, Maeda
Yamashita, Masuo
Tsugawa, Masaya
[J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2020, 26 (05) : 418 - 428

← 1 2 →